Clinical Trials Directory

Trials / Completed

CompletedNCT04063423

Non- Clinical Coagulation Activation During Hemodialysis

Non- Clinical Coagulation Activation During Hemodialysis: a Cross-sectional Study Evaluating Agreement and Correlation Between Hemodialysis Session Parameters, Biological Markers and Objective Measurements of Hemodialyzers: "NC-coact"

Status
Completed
Phase
Study type
Observational
Enrollment
32 (actual)
Sponsor
Universitair Ziekenhuis Brussel · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Every patient included in the study will undergo 1 conventional hemodialysis treatment, ie 1 study visit. During the conventional hemodialysis treatment lasting 4 hours, 2 blood samples will be taken at different time points (5 minutes after dialysis start and 240 minutes after dialysis = at the end of the dialysis session) to evaluate coagulation activation (TAT, PF1+2). Hemodialysis session parameters (arterial and venous pressure, TMP, OCM, BVM and prefilter pressure) will be noted at different time points (T5, T30, T60, T120, T180, T240). After discontinuation of the dialysis session, total cell volume will be measured using the Renatron II system® and the number of open fibers will be determined using micro-CT scanning.

Conditions

Interventions

TypeNameDescription
PROCEDUREblood sampleBlood sample at start and at the end of the dialysis session; membrane scoring after dialysis; total cell volume measurement of dialyzer after dialysis; micro-CT of dialyzer after dialysis.

Timeline

Start date
2018-10-25
Primary completion
2019-05-01
Completion
2019-05-01
First posted
2019-08-21
Last updated
2019-08-21

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04063423. Inclusion in this directory is not an endorsement.